Mechanisms of organoselenium compounds in chemoprevention: Effects on transcription factor-DNA binding

Nutrition and Cancer

Volumn 40, Issue 1, 2001, Pages 28-33

  Youn, B W ^a   Fiala, E S ^a   Sohn, O S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE; ORGANOSELENIUM DERIVATIVE; SODIUM SELENITE; SULFUR DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BINDING SITE; CANCER CELL CULTURE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PROTEIN DNA BINDING; REVIEW;

EID: 0035678697     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc401_7     Document Type: Review

References (31)

1. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
2. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
3. Reduction of cancer mortality and incidence by selenium supplementation
4. Chemoprevention of cancer by organoselenium compounds
5. Lessons from basic research in selenium and cancer prevention
6. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate
7. Control of apoptosis by Re/NF-κB transcription factors
8. Aberrant rel/nfkb genes and activity in human tumors
9. Diverse agents act at multiple levels to inhibit the Re/NF-κB signal transduction pathway
10. Selenium-mediated inhibition of transcription factor NF-κB and HIV-1 LTR promotor activity
11. Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment
12. Redox regulation of transcriptional activators
13. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis
14. AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione
15. Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos
16. A tale of three fingers: The family of mammalian Sp/XKLF transcription factors
17. Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1
18. Transcriptional regulation by the Sp family members
19. Waf1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members
20. Transcriptional analysis of human survivin gene expression
21. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells
22. Sp1 elements protect a CpG island from de novo methylation
23. Sp1 sites in the mouse aprt gene promotor are required to prevent methylation of the CpG island
24. Trancription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation
25. Site-specific DNA methylation in the neurofibromatosis (NF1) promotor with binding of CREB and SP1 transcription factors
26. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line
27. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT-29)
28. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
29. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
30. Transcriptional cross talk between NF-κB and p53
31. Activators and target genes of Re/NF-κB transcription factors